{"id":56157,"date":"2023-04-24T21:05:21","date_gmt":"2023-04-24T19:05:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/"},"modified":"2023-04-24T21:05:21","modified_gmt":"2023-04-24T19:05:21","slug":"breaking-through-untreatable-depression-and-anxiety-with-ketamine","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/","title":{"rendered":"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine"},"content":{"rendered":"
\n

\nAn Educational Session with Psychiatrist Dr. Stephen Manlove<\/p>\n

<\/a><\/p>\n

RAPID CITY, S.D.–(BUSINESS WIRE)–For 30% of patients with depression, common antidepressants don\u2019t work. Specializing in treating the most interminable depression cases, Manlove Brain + Body Clinic<\/a> has been using ketamine for four years to help patients with \u2018untreatable\u2019 depression or anxiety make significant breakthroughs. 70% of treatment resistant depression (TRD) patients have seen a significant improvement in their depression symptoms with ketamine, compared to the 10% chance they would see if they tried yet another common antidepressant medication. In some cases, patients even find that their depression is eliminated completely.<\/p>\n

\n\u201cSeveral years ago I considered leaving the practice of medicine because at the end of the day, all I could think about were my patients who never seemed to get better no matter what we tried,\u201d said Dr. Manlove. Instead of leaving, he decided to take a new approach. Where Dr. Manlove found scientifically based positive outcomes, he incorporated new treatment modalities and technologies and finally saw breakthroughs with many of his toughest cases.<\/p>\n

\n\u201cWe found that when we treat patients holistically-working to improve their health in as many areas as possible such as nutrition, exercise, and stress management- we can improve the brain\u2019s ability to function and respond to psychiatric treatments,\u201d says Dr. Manlove.<\/p>\n

\nPsychiatrist Dr. Stephen Manlove is hosting a free educational session\u2013Ketamine for Depression and Anxiety\u2013at the Rapid City Public Library on Monday, May 1st from 5:30-6:30pm. In this talk, Dr. Manlove will explain how ketamine works differently from common antidepressant medications, who may benefit from it, and the risks and side effects to consider. Registration<\/a> is required as seating is limited.<\/p>\n

\nEvent: <\/b>Ketamine for Depression and Anxiety<\/a><\/b><\/p>\n

\nLocation<\/b>: Rapid City Public Library 610 Quincy Street Rapid City, SD 57701 – Community Room, 2nd Floor<\/p>\n

\nDate & Time<\/b>: Monday May 1st, 5:30-6:30pm (doors open at 5pm)<\/p>\n

\nRegistration<\/b>: Please register here<\/a>.<\/p>\n

\nJoin Dr. Manlove for Predicting Violence<\/a><\/b> on May 15th.<\/p>\n

\nAbout Manlove Brain and Body Health<\/b><\/p>\n

\nManlove Brain and Body Health<\/a> is a people-focused psychiatric clinic located in Rapid City. Their team of mental health providers can help with a broad range of psychiatric conditions including depression, anxiety, bipolar disorder, ADHD, dementia, and more. Specializing in treatment-resistant depression, MBBH offers cutting-edge treatment methods such as Transcranial Magnetic Stimulation (TMS), ketamine\/esketamine (Spravato), genetics, and extensive laboratory analysis.<\/p>\n

Contacts<\/b> <\/p>\n

\nBob Brin
\n
651-331-6183
\n
ebobmn@gmail.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

An Educational Session with Psychiatrist Dr. Stephen Manlove RAPID CITY, S.D.–(BUSINESS WIRE)–For 30% of patients with depression, common antidepressants don\u2019t work. Specializing in treating the most interminable depression cases, Manlove Brain + Body Clinic has been using ketamine for four years to help patients with \u2018untreatable\u2019 depression or anxiety make significant breakthroughs. 70% of treatment … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56157","6":"format-standard","7":"category-industry"},"yoast_head":"\nBreaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"An Educational Session with Psychiatrist Dr. Stephen Manlove RAPID CITY, S.D.–(BUSINESS WIRE)–For 30% of patients with depression, common antidepressants don\u2019t work. Specializing in treating the most interminable depression cases, Manlove Brain + Body Clinic has been using ketamine for four years to help patients with \u2018untreatable\u2019 depression or anxiety make significant breakthroughs. 70% of treatment ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-24T19:05:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230424005825\/en\/1772371\/21\/MBBH_primary-logo_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine\",\"datePublished\":\"2023-04-24T19:05:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/\"},\"wordCount\":407,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005825\\\/en\\\/1772371\\\/21\\\/MBBH_primary-logo_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/\",\"name\":\"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005825\\\/en\\\/1772371\\\/21\\\/MBBH_primary-logo_RGB.jpg\",\"datePublished\":\"2023-04-24T19:05:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005825\\\/en\\\/1772371\\\/21\\\/MBBH_primary-logo_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005825\\\/en\\\/1772371\\\/21\\\/MBBH_primary-logo_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/","og_locale":"en_US","og_type":"article","og_title":"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine - Pharma Trend","og_description":"An Educational Session with Psychiatrist Dr. Stephen Manlove RAPID CITY, S.D.–(BUSINESS WIRE)–For 30% of patients with depression, common antidepressants don\u2019t work. Specializing in treating the most interminable depression cases, Manlove Brain + Body Clinic has been using ketamine for four years to help patients with \u2018untreatable\u2019 depression or anxiety make significant breakthroughs. 70% of treatment ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-24T19:05:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230424005825\/en\/1772371\/21\/MBBH_primary-logo_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine","datePublished":"2023-04-24T19:05:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/"},"wordCount":407,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230424005825\/en\/1772371\/21\/MBBH_primary-logo_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/","url":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/","name":"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230424005825\/en\/1772371\/21\/MBBH_primary-logo_RGB.jpg","datePublished":"2023-04-24T19:05:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230424005825\/en\/1772371\/21\/MBBH_primary-logo_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230424005825\/en\/1772371\/21\/MBBH_primary-logo_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/breaking-through-untreatable-depression-and-anxiety-with-ketamine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Breaking Through \u2018Untreatable\u2019 Depression and Anxiety with Ketamine"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56157"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56157\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}